Eylea (Aflibercept) PK Simulator
Indication: Wet age-related macular degeneration
Simulate Eylea (aflibercept) pharmacokinetics. This PK simulator models the VEGF trap fusion protein used for wet AMD, diabetic macular edema, and retinal vein occlusion.
Drug Overview
Clinical Context
- Molecular Target
- VEGF-A/VEGF-B/PlGF
- Drug Class
- Fusion Protein
- Therapeutic Area
- Ophthalmology
- Indication
- Wet age-related macular degeneration
- Route of Administration
- IVT
Model Information
- Model Type
- 2-CMT PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Eylea (Aflibercept) allows you to explore concentration-time profiles under different dosing scenarios. The underlying 2-CMT PopPK model characterizes the pharmacokinetics of this fusion protein following ivt administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Eylea (Aflibercept) PK simulator?
This is a free, interactive pharmacokinetic simulator for Eylea (Aflibercept) used in Wet age-related macular degeneration. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Eylea (Aflibercept) belong to?
Eylea (Aflibercept) is classified as a Fusion Protein that targets VEGF-A/VEGF-B/PlGF. It is used in the Ophthalmology therapeutic area.
What route of administration does this model simulate?
This simulator models IVT administration of Eylea (Aflibercept). The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a 2-CMT PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the Eylea (Aflibercept) simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community